Department of Surgery, Surgical Outcomes Analysis and Research (SOAR), University of Massachusetts Medical School, Worcester, MA, USA.
HPB (Oxford). 2014 Mar;16(3):275-81. doi: 10.1111/hpb.12125. Epub 2013 Jul 22.
Pancreaticoduodenal trauma (PDT) is associated with substantial mortality and morbidity. In this study, contemporary trends were analysed using national data.
The Nationwide Inpatient Sample for 1998-2009 was queried for patients with PDT. Interventions including any operation (Any-Op) and pancreas-specific surgery (PSURG) were identified. Trends in treatment and outcomes were determined [complications, length of stay (LoS), mortality] for the Any-Op, PSURG and non-operative (Non-Op) groups. Analyses included chi-squared tests, Cochran-Armitage trend tests and logistic regression.
A total of 27 216 patients (nationally weighted) with PDT were identified. Over time, the frequency of PDT increased by 8.3%, whereas the proportion of patients submitted to PSURG declined (from 21.7% to 19.8%; P = 0.0004) and the percentage of patients submitted to non-operative management increased (from 56.7% to 59.1%; P = 0.01). In the Non-Op group, mortality decreased from 9.7% to 8.6% (P < 0.001); morbidity and LoS remained unchanged at ∼40% and ∼12 days, respectively. In the PSURG group, mortality remained stable at ∼15%, complications increased from 50.2% to 71.8% (P < 0.0001) and LoS remained stable at ∼21 days. For all PDT patients, significant independent predictors of mortality included: the presence of combined pancreatic and duodenal injuries; penetrating trauma, and age >50 years. Having any operation (Any-Op) was associated with mortality, but PSURG was not a predictor of death.
The utilization of operations for PDT has declined without affecting mortality, but operative morbidity increased significantly over the 12 years to 2009. The development of an evidence-based approach to invasive manoeuvres and an early multidisciplinary approach involving pancreatic surgeons may improve outcomes in patients with these morbid injuries.
胰十二指肠创伤(PDT)与较高的死亡率和发病率相关。本研究利用国家数据分析了其当代趋势。
1998 年至 2009 年,通过国家住院患者样本(Nationwide Inpatient Sample)调查 PDT 患者。确定了包括任何手术(Any-Op)和胰腺特定手术(PSURG)在内的干预措施。对于 Any-Op、PSURG 和非手术(Non-Op)组,确定了治疗和结果的趋势(并发症、住院时间(LoS)、死亡率)。分析包括卡方检验、Cochran-Armitage 趋势检验和逻辑回归。
共确定了 27216 名 PDT 患者(全国加权)。随着时间的推移,PDT 的发生率增加了 8.3%,而接受 PSURG 的患者比例下降(从 21.7%降至 19.8%;P = 0.0004),接受非手术治疗的患者比例增加(从 56.7%增至 59.1%;P = 0.01)。在 Non-Op 组,死亡率从 9.7%降至 8.6%(P < 0.001);发病率和 LOS 分别约为 40%和 12 天,保持不变。在 PSURG 组,死亡率稳定在约 15%,并发症从 50.2%增加到 71.8%(P < 0.0001),而 LOS 保持在 21 天左右。对于所有 PDT 患者,死亡率的独立预测因素包括:胰腺和十二指肠联合损伤的存在;穿透性创伤,以及年龄 >50 岁。进行任何手术(Any-Op)与死亡率相关,但 PSURG 不是死亡的预测因素。
PDT 手术的使用减少了,但在 12 年至 2009 年期间,手术发病率显著增加。采用循证方法进行侵袭性操作,并建立早期多学科方法,让胰腺外科医生参与其中,可能会改善这些严重损伤患者的预后。